{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T14:04:37Z","timestamp":1794233077353,"version":"4.9.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.pan.2018.01.009","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T12:51:31Z","timestamp":1517489491000},"page":"298-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors"],"prefix":"10.1016","volume":"18","author":[{"given":"A.B.","family":"C\u00e2mara-de-Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.K.","family":"Toyoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Giannella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.S.","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.P.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"D.M.","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bacchella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Jureidini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.C.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.Q.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.A.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2018.01.009_bib1","first-page":"417","article-title":"Insulinoma: clinical and diagnostic features of 60 consecutive cases","volume":"51","author":"Service","year":"1976","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pan.2018.01.009_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpg.2005.05.008","article-title":"Insulinoma","volume":"19","author":"Grant","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.pan.2018.01.009_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pan.2018.01.009_bib4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/BF03344176","article-title":"Endogenous hyperinsulinemic hypoglycemia: diagnostic strategies, predictive features of malignancy and long-term survival","volume":"29","author":"Queiroz Almeida","year":"2006","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.pan.2018.01.009_bib5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cncr.21179","article-title":"Malignant insulinoma: spectrum of unusual clinical features","volume":"104","author":"Hirshberg","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.pan.2018.01.009_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.diabet.2008.01.013","article-title":"Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: a retrospective 35-year study of 12 patients","volume":"34","author":"Begu-Le Corroller","year":"2008","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.pan.2018.01.009_bib7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ando.2013.07.001","article-title":"Malignant insulinoma: recommendations for characterisation and treatment","volume":"74","author":"Baudin","year":"2013","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.pan.2018.01.009_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MPA.0000000000000718","article-title":"A\u00a0clinicopathological study of malignant insulinoma in a contemporary series","volume":"46","author":"Yu","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2018.01.009_bib9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.5858\/2004-128-426-CPFMWT","article-title":"Cellular proliferative fraction measured with topoisomerase IIalpha predicts malignancy in endocrine pancreatic tumors","volume":"128","author":"Diaz-Rubio","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pan.2018.01.009_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000095926","article-title":"Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status","volume":"115","author":"Jonkers","year":"2017","journal-title":"Cytogenet Genome Res"},{"key":"10.1016\/j.pan.2018.01.009_bib11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2559.2007.02662.x","article-title":"Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours","volume":"50","author":"La Rosa","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.pan.2018.01.009_bib12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1677\/ERC-07-0111","article-title":"DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients","volume":"14","author":"Jonkers","year":"2007","journal-title":"Endocr Relat Canc"},{"key":"10.1016\/j.pan.2018.01.009_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/modpathol.2014.82","article-title":"Novel prognostic markers revealed by a proteomic approach separating benign from malignant insulinomas","volume":"28","author":"Alkatout","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pan.2018.01.009_bib14","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pan.2018.01.009_bib15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/j.seminoncol.2010.10.014","article-title":"Pancreatic endocrine tumors","volume":"37","author":"Oberg","year":"2010","journal-title":"Semin Oncol"},{"key":"10.1016\/j.pan.2018.01.009_bib16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0b013e3181ec124e","article-title":"The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems","volume":"39","author":"Klimstra","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2018.01.009_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jso.21773","article-title":"Surgical management of patients with insulinomas: result of 292 cases in a single institution","volume":"103","author":"Zhao","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.pan.2018.01.009_bib18","first-page":"2099","article-title":"Surgical treatment of pancreatic islet cell tumor: report of 44 cases","volume":"60","author":"Guo","year":"2013","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.pan.2018.01.009_bib19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3748\/wjg.v19.i6.829","article-title":"Diagnosis and management of insulinoma","volume":"19","author":"Okabayashi","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pan.2018.01.009_bib20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1210\/jc.2008-2031","article-title":"Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007","volume":"94","author":"Placzkowski","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pan.2018.01.009_bib21","first-page":"854","article-title":"Insulinoma: diagnostic strategies and surgical treatment. A 22-year experience","volume":"48","author":"Machado","year":"2001","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.pan.2018.01.009_bib22","first-page":"189","article-title":"Malignant insulinoma: report of 6 patients and literature review","volume":"37","author":"Shao","year":"2016","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.pan.2018.01.009_bib23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12094-012-0996-7","article-title":"Management of malignant insulinoma","volume":"15","author":"Ferrer-Garcia","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.pan.2018.01.009_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/PAS.0b013e3181874eca","article-title":"Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia","volume":"33","author":"Anlauf","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pan.2018.01.009_bib25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.pan.2014.07.011","article-title":"Management of a metastasized high grade insulinoma (G3) with refractory hypoglycemia: case report and review of the literature","volume":"14","author":"Scharf","year":"2014","journal-title":"Pancreatology"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390318300127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390318300127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:06:43Z","timestamp":1761408403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390318300127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1424390318300127"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2018.01.009","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2018.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 IAP and EPC. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}